ABPO
Abpro Holdings, Inc.
$0.21
-0.01 (-5.78%)
At close · Jul 2
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, based on the considerations discussed above, management has concluded there is substantial doubt as to the Company’s ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 20, 2026
Market Cap
$1.25M
Shares
5,896,048
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.21
Open$0.23
Day$0.19–0.23
52W$0.09–13.65
Avg vol 30d18K
Short int34K · 0.6% float · 1.0d
Short vol73%
DataMar 2022–Jul 2026
Filing10-Q · May 20
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−92% below
+
Price vs 50-day avg
+7% above
◦
RSI (14)
51 · neutral
+
MACD trend
positive
−
52-week position
1% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $3 — 200d above 50d
+
Institutional flow
+9 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.57% of float · ▼ -22.1% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
9 holders — 13F breadth
Fundamentals
Excellent
+
Revenue growth
+50% Y/Y
+
EPS growth
+94% Y/Y
−
Free cash flow
$-6.1M
+
Valuation
P/E 0.3 · below peers
+
Balance sheet
net cash $2.9M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 20, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−92% below
Bearish
Price vs 50-day avg
+7% above
Bullish
RSI (14)
51 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
1% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.57% of float · ▼ -22.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 1%
52-wk high $14
vs 200-day avg -92%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABPO
this stock
Abpro Holdings, Inc.
|
$1.25M | -95.0% | +50.0% | 0.3 | 0.6% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
9
- % held
- 0.8%
- Net QoQ
- +46.5K sh
- Top holder
- VANGUARD GROUP INC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABPO | -2.3% | +3.4% | -94.8% | +6.5% | -95.0% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -3.7% | +4.7% | -102.8% | +6.8% | -104.2% |